Wezenla
ustekinumab
Psoriasis
Arthritis, Psoriatic
Crohn Disease
Opinion date:
Last updated:
MedicineHumanOpinion
Stelara
ustekinumab
Psoriasis
Arthritis, Psoriatic
Crohn Disease
Colitis, Ulcerative
Date of authorisation:
Revision: 46
Last updated:
MedicineHumanAuthorised
Pyzchiva
ustekinumab
Crohn Disease
Colitis, Ulcerative
Arthritis, Psoriatic
Opinion date:
Last updated:
MedicineHumanOpinion
Uzpruvo
ustekinumab
Psoriasis
Arthritis, Psoriatic
Crohn Disease
Colitis, Ulcerative
Date of authorisation:
Last updated:
MedicineHumanAuthorised
EMEA-000311-PIP04-13-M04 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Gastroentology-Hepatology
PIP number: P/0401/2022
Route(s) of administration: Subcutaneous useIntravenous use
Pharmaceutical form(s):
Solution for injection/infusion
Concentrate for solution for infusion
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Xalkori
crizotinib
Carcinoma, Non-Small-Cell Lung
Date of authorisation:
Revision: 33
Last updated:
MedicineHumanAuthorised
EMEA-000311-PIP05-17-M02 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Gastroentology-Hepatology
PIP number: P/0281/2020
Route(s) of administration: Intravenous useSubcutaneous use
Pharmaceutical form(s):
Concentrate for solution for infusion
Solution for injection/infusion
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-001493-PIP03-18-M01 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Oncology
PIP number: P/0036/2021
Route(s) of administration: Oral use
Pharmaceutical form(s):
Capsule (hard)
Age-appropriate oral dosage form
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000311-PIP03-11-M06 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Immunology-Rheumatology-Transplantation
PIP number: P/0467/2020
Route(s) of administration: Subcutaneous useIntravenous use
Pharmaceutical form(s):
Solution for injection
Solution for injection (in pre-filled syringe)
Concentrate for solution for infusion
Decision date:
Last updated:
Compliance check: ✖
PIPHuman